SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-029228
Filing Date
2024-07-26
Accepted
2024-07-26 16:05:15
Documents
21
Period of Report
2024-07-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52611
2 ex1-1.htm EX-1.1 145602
3 ex4-1.htm EX-4.1 134765
4 ex4-2.htm EX-4.2 118690
5 ex4-3.htm EX-4.3 374303
6 ex10-1.htm EX-10.1 246375
7 ex99-1.htm EX-99.1 11459
8 ex99-2.htm EX-99.2 10475
9 ex1-1_001.jpg GRAPHIC 4233
  Complete submission text file 0001493152-24-029228.txt   1503997

Data Files

Seq Description Document Type Size
10 aztr-20240723.xsd EX-101.SCH 3018
11 aztr-20240723_lab.xml EX-101.LAB 34240
12 aztr-20240723_pre.xml EX-101.PRE 22361
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3712
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

IRS No.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 241146801
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)